Cancer Center Support Grant-P30

描述（由申请人提供）：加州大学戴维斯分校癌症中心是劳伦斯利弗莫尔国家实验室（LLNL）的综合项目，是加州大学戴维斯分校卫生系统（结合加州大学戴维斯分校医学院和加州大学戴维斯分校医学中心）和加州大学戴维斯分校支持下的矩阵组织。癌症中心位于加州大学戴维斯分校医学中心（萨克拉门托，加州）的校园内，其行政、临床和研究设施由此次P30竞争性续约的主要研究者领导; 2002年7月1日，癌症中心获得了初始P30。癌症中心从加州大学戴维斯分校的教师和LLNL、美国农业部西部人类营养研究中心和加州公共卫生部的研究人员中吸引了186名成员。加州大学戴维斯分校癌症中心成员的同行评审资金总额为81，918，736.00美元，其中21，771，164.00美元（直接费用）由NCI提供。其他组织的研究人员也分别通过美国能源部、美国农业部和加州州获得研究资金。在加州大学戴维斯分校癌症中心，研究分为六个项目：（1）分子肿瘤学，（2）比较肿瘤学，（3）癌症治疗学，（4）人口科学和健康差异，（5）前列腺癌，（6）生物医学技术。 P30 [癌症中心支持补助金]的竞争性更新建议支持（1）高级领导，（2）项目领导，（3）开发项目，（4）管理，（5）规划和评估活动，（6）九个共享资源，包括基因组学，光学生物学，小鼠生物学，临床试验支持单位，生物统计学，临床和分子药理学，动物成像，生物样本库和组合化学，（7）方案审查和监测系统，（8）方案特定研究，以及（9）数据安全和监测。

DESCRIPTION (provided by applicant): The UC Davis Cancer Center, an integrated program with Lawrence Livermore National Labs (LLNL), is a matrix organization under the aegis of the UC Davis Health System (combining the UC Davis School of Medicine and the UC Davis Medical Center), and the University of California, Davis. Located on the campus of the UC Davis Medical Center in Sacramento, California, the cancer center's administrative, clinical and research facilities are under the leadership of the Principal Investigator of this P30 competitive renewal; an initial P30 was awarded to the Cancer Center on July 1, 2002. The Cancer Center draws its 186 members from the faculty of UC Davis and investigators at the LLNL, the USDA Western Human Nutrition Research Center and the California Department of Public Health. Peer-reviewed funding for UC Davis Cancer Center members totals $81,918,736.00 of which $21,771,164.00 (direct costs) is provided by the NCI. Investigators at the other organizations contributing membership are also provided research funding through the US Department of Energy, the US Department of Agriculture, and the State of California respectively. At the UC Davis Cancer Center, research is organized into six programs: (1) Molecular Oncology, (2) Comparative Oncology, (3) Cancer Therapeutics, (4) Population Sciences and Health Disparities, (5) Prostate Cancer, (6) Biomedical Technology. This competitive renewal for the P30 [Cancer Center Support Grant] proposes support for (1) senior leadership, (2) program leadership, (3) developmental programs, (4) administration, (5) planning and evaluation activities, (6) nine shared resources including genomics, optical biology, mouse biology, the clinical trials support unit, biostatistics, clinical and molecular pharmacology, animal imaging, biospecimen repository and combinatorial chemistry, (7) the Protocol Review and Monitoring System, (8) protocol-specific research, and (9) Data Safety and Monitoring.